<DOC>
	<DOCNO>NCT01071499</DOCNO>
	<brief_summary>The purpose study identify collect sample child take single oral dose pain medication morphine , determine genetic difference way child metabolize ( break body affect ) morphine .</brief_summary>
	<brief_title>Pharmacokinetics Oral Morphine Pharmacogenomics CYP2D6 UGT2B7 , Urban Pediatric Population Presenting Elective Surgery</brief_title>
	<detailed_description>Hypothesis : Oral morphine produce reliable peak plasma morphine concentration reliable analgesia codeine , currently drug choice . Background : Codeine commonly use oral opiate analgesia child . Codeine pro-drug require activation isozyme CYP2D6 . Genetically determine variation activity CYP2D6 result inappropriately low analgesic efficacy due inadequate conversion drug `` poor-metabolizers '' conversely , adverse reaction respiratory depression death `` ultra-metabolizers '' . In ethnic group many 40 % patient may susceptible concentration-dependent toxicity great expect metabolism codeine morphine . We hypothesize oral morphine feasible safe alternative codeine . The primary aim study define trial appropriate dose morphine provide child effective reliable perioperative analgesia minimum risk adverse drug effect . A secondary aim investigate pharmacogenetics codeine morphine metabolism child . Specific Objectives : The pharmacokinetic property 3 ( 0.1 mg/kg , 0.2 mg/kg 0.3 mg/kg ) dose oral morphine describe . We determine dose oral morphine result peak plasma concentration occur within 60 - 90 min result analgesic therapeutic range ( 10 - 40 ng/mL ) . Pharmacogenetic profile two key enzyme involve codeine morphine metabolism ( CYP2D6 UGT2B7 ) determine . Methods : After obtain institutional review board approval , write parental informed consent , recruit 45 child Phase I age 2-6 year undergo elective surgery . A perceived ethnicity questionnaire also administer . Subjects recruit Phase I block assign one three dos morphine . In Phase I , sample do 4 hrs determine key pharmacokinetic parameter include Tmax , Cmax AUC . Monitoring occur throughout analgesic efficacy adverse effect measure post-operatively . All subject receive 24 hr telephone follow analgesic efficacy adverse drug effect . Data Analysis : All continuous parametric data ( weight , age , BMI ) analyze use t-tests . Non-parametric ordinal data pain score analyze Mann-Whitney U test .</detailed_description>
	<mesh_term>Morphine</mesh_term>
	<criteria>2 6 year age ASA 1 &amp; 2 elective surgical patient Procedures require opioid analgesia Minimal hospital stay 4 hr Informed consent Allergy adverse reaction morphine Contraindication morphine analgesia , potential difficult airway Abnormal hepatic renal function know history available laboratory result Current regular opioid use Surgical anesthetic contraindication oral premedication gastroesophageal reflux disease Children BMI &lt; 10'ile &gt; 90'ile Declines study participation</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacogenetics</keyword>
	<keyword>morphine</keyword>
	<keyword>child</keyword>
</DOC>